Cord Blood News 10.11 March 22, 2018 | |
| |
TOP STORYMolecular Transitions in Early Progenitors during Human Cord Blood Hematopoiesis The authors leveraged Drop‐seq, a massively parallel single‐cell RNA sequencing approach, to individually profile 20,000 progenitor cells from human cord blood, without prior enrichment or depletion for individual lineages based on surface markers. [Mol Syst Biol] Abstract | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Investigators compared MSCs derived from different perinatal tissues, including the umbilical cord, amniotic membrane, chorionic plate and decidua parietalis. Using human leukocyte antigen typing and karyotype analysis, they found that the first three cell types were derived from the fetus, while the MSCs from the decidua parietalis were derived from the maternal portion of the placental tissue. [Sci Rep] Full Article The authors present detailed analyses of human leukocyte antigen (HLA)-G-levels in patients after allogeneic stem cell transplantation showing a correlation of elevated soluble HLA-G levels with less severe acute and chronic graft-versus-host disease and with a superior overall survival. [Bone Marrow Transplant] Abstract Scientists demonstrated that functional organic cation transporters are expressed in human-derived MSCs from umbilical cord Wharton’s jelly, an inexhaustible source of nonembryonic MSCs with proven osteogenic potential. [Cytotherapy] Abstract Transplantation of collagen/umbilical cord (UC)-MSCs to the ovaries of premature ovarian failure (POF) patients rescued overall ovarian function, evidenced by elevated estradiol concentrations, improved follicular development, and increased number of antral follicles. [Sci China Life Sci] Abstract Researchers explored a suitable way to isolate and culture the buffalo amniotic mesenchymal stem cells, and to identify their biological characteristics. [J Vet Med Sci] Abstract | |
| |
REVIEWSTransplantation and Alternatives to Treat Autoimmune Diseases Cord blood transplantation is favored over other transplant techniques. The propelled treatments incorporate interferon administrative elements and mesenchymal stromal cells for the management of immune system issue particularly in the treatment of rheumatoid joint inflammation. [Adv Exp Med Biol] Abstract Visit our reviews page to see a complete list of reviews in the cord blood research field. | |
| |
SCIENCE NEWSGamida Cell to Present Immune Reconstitution Data for its NiCord® Program Gamida Cell announced that new data on immune reconstitution from its Phase I/II study of NiCord in high-risk hematologic malignancies will be presented. [Press release from Gamida Cell discussing research to be presented at the 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), Lisbon] Press Release | |
| |
INDUSTRY NEWSFDA approved Adcetris to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma in combination with chemotherapy. [The U.S. Food and Drug Administration] Press Release Novartis Drug Tasigna® Approved by FDA to Treat Children with Rare Form of Leukemia Novartis announced that the FDA expanded the indication for Tasigna® to include treatment of first- and second-line pediatric patients one year of age or older with Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase. [Novartis] Press Release AbbVie and the International Myeloma Foundation announced they have entered into a collaboration to conduct a landmark retrospective chart review study to better understand and help manage multiple myeloma, the second most common blood cancer. [AbbVie Inc.] Press Release | |
| |
POLICY NEWSUS Science Agencies Set to Win Big in Budget Deal Nearly all US science agencies would see their budgets grow in 2018, under a US$1.3-trillion spending deal announced. For the second year in a row, lawmakers in Congress seem set to ignore the steep cuts sought by President Donald Trump. [Nature News] Editorial Expectations Are High for UKRI, the United Kingdom’s New £6 Billion Research Behemoth Combine U.S. agencies akin to the National Institutes of Health, National Science Foundation, and National Endowment for the Humanities. Toss in some energy and innovation research and fuel it all with the largest boost in R&D spending in recent history. Then put one person in charge. [ScienceInsider] Editorial HIV Researcher Is New Head of US Public-Health Agency HIV researcher Robert Redfield will lead the Centers for Disease Control and Prevention, Secretary of Health and Human Services Alex Azar announced. [Nature News] Editorial
| |
EVENTSNEW Arizona Cord Blood Conference 2018 – Advancing Innovation Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Scholar – Hematology (Huntsman Cancer Institute) NEW Postdoctoral Scholar – Clonal Hematopoiesis (Stanford University) Postdoctoral Fellow – Leukemia (Washington University) Postdoctoral Fellowship – Cell and Molecular Biology (Canadian Nuclear Laboratories) Postdoctoral Positions – Molecular Biology (Memorial Sloan Kettering Cancer Center) Postdoctoral Fellow & Scientist – Acute Myeloid Leukemia (Institute of Hematology) Postdoctoral Fellowship – Functional Genomics of Human Hematopoiesis (Boston Children’s Hospital) Postdoctoral Research Fellow – Fanconi Anemia (Cincinnati Children’s Hospital Medical Center) Scientific Manager – Cell Engineering Lab (Genentech, Inc.) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Cord Blood News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|